The Programmatic Hemosorption in the Comprehensive Treatment of Atherosclerosis of Various Localisation Hemosorption in the treatment of atherosclerosis
Autor: | Teterina Eb, Moreino Ms, E.S. Nalivaiko, S.S. Markin, Fedin Ai, E.M. Khalilov, Kaminka TYa, Belousov YuB |
---|---|
Rok vydání: | 1987 |
Předmět: |
medicine.medical_specialty
Arteriosclerosis business.industry medicine.medical_treatment Encephalopathy Coronary Disease Normal level General Medicine Disease medicine.disease Hemosorption Hemoperfusion Lipids Brain Ischemia Surgery Microcirculation Hyperlipoproteinemia Type II Brain ischemia Internal medicine medicine Cardiology Humans business |
Zdroj: | Biomaterials, Artificial Cells and Artificial Organs. 15:125-135 |
ISSN: | 0890-5533 |
DOI: | 10.3109/10731198709118513 |
Popis: | The inclusion of hemosorption through activated coals into the comprehensive treatment of 580 patients sick with atherosclerosis has made it possible to achieve a positive clinical effect among 81 per cent of the patients sick with the ischemic heart disease, 79 per cent of atherosclerotic discirculatory encephalopathy and 76 per cent of obliterating atherosclerosis of lower limbs. The positive dynamics is especially visible among patients who are administered the programmatic hemosorption, making it possible over a long period of time (3-5 years) to sustain remission in the clinical state and the normal level of the lipids in the blood. The direct effect is expressed in the improved microcirculation, disappearance of the sludge-syndrome and the reduction of ischemic disorders. The remote effect of hemosorption is connected with the repeated removals of cholesterin of the atherogenic lipoproteids, which leads, we believe, to the interruption or even regression of the atherosclerotic process. |
Databáze: | OpenAIRE |
Externí odkaz: |